Endothelial nitric oxide synthase-Akt signaling pathway (Akt/eNOS pathway)

The Endothelial nitric oxide synthase (eNOS)-Akt signaling pathway is a fundamental regulatory axis for vascular homeostasis and endothelial function (UniProt P29474, P31749). This pathway is activated by various stimuli, including mechanical shear stress and biochemical factors like insulin and vascular endothelial growth factor (VEGF), which trigger the Phosphoinositide 3-kinase (PI3K) cascade (PMID: 10866611). A key step in this process is the phosphorylation of eNOS at the Ser1177 residue by the serine/threonine kinase Akt, which significantly boosts nitric oxide (NO) production (PMID: 11055975). The resulting NO diffuses into vascular smooth muscle cells to induce relaxation and vasodilation, while also providing anti-thrombotic and anti-inflammatory protection to the vessel wall. Dysregulation or 'uncoupling' of this pathway is a hallmark of endothelial dysfunction, contributing to the development of atherosclerosis, hypertension, and diabetic complications (StatPearls: Endothelial Dysfunction). Pharmacological agents such as statins and certain antihypertensives are known to enhance Akt-mediated eNOS activation, thereby improving vascular health and reducing cardiovascular events.

Other names

PI3K/Akt/eNOS axisAkt-eNOS signalingProtein kinase B-Endothelial nitric oxide synthase pathway

Activation of the PI3K/Akt signaling cascade leads to the direct phosphorylation of eNOS at Ser1177 by Akt, which increases the enzyme's catalytic activity and the bioavailability of nitric oxide in the endothelium (PMID: 11055975).